Retatrutide 5mg

Retatrutide 5mg, Retatrutide (LY3437943) is a novel, investigational triple hormone receptor agonist designed to simultaneously target the GLP-1, GIP, and glucagon receptors. As a synthetic peptide, Retatrutide is under active clinical investigation for its promising role in metabolic regulation, including weight management, glucose control, and lipid metabolism.

Key Features: Retatrutide 5mg

• Potent Multi-Receptor Agonist: Simultaneous action on GLP-1, GIP, and glucagon receptors, enabling synergistic metabolic effects.

• High Purity (≥98%): Manufactured to stringent research-grade standards for consistent results.

• Lyophilized Powder Form: Ensures long-term stability and easy reconstitution.

• 5mg per Vial: Precisely dosed for accurate, scalable experimentation.

Applications:

• Preclinical research in obesity, diabetes, and metabolic disorders.

• Mechanistic studies involving incretin and glucagon pathways.

• Exploration of combination therapies in endocrine and metabolic modulation.

Storage & Handling:

• Store at -20°C.

• Reconstitute with sterile bacteriostatic water or an appropriate solvent for in vitro or in vivo use.